IRIS
NOBILI, FLAVIO MARIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 39.543
Totale 39.543
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 39.543
Totale 39.543
Salva come PNG Salva come JPEG
Città #
Genova 29.962
Rapallo 4.593
Genoa 3.649
Vado Ligure 1.229
Bordighera 110
Totale 39.543
Salva come PNG Salva come JPEG
Nome #
The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. 242
An updated Italian normative dataset for the Stroop color word test (SCWT) 167
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 165
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 154
A normative study of the Italian printed word version of the free and cued selective reminding test 149
Psychological and social aspects in management of Alzheimer’s patients: an inquiry among caregivers. 147
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 146
Pulsatile electrical impedance response from cerebrally dead adult patients is not a reliable tool for detecting cerebral perfusion changes 144
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 144
Amyloid positron emission tomography and cognitive reserve. 144
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 141
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 138
Cerebral Blood Flow and plasma free Tryptophan in cirrhotics with and without hepatic encephalopathy. 137
Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease 136
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 136
Fronto-parietal coupling of brain rhythms in mild cognitive impairment: A multicentric EEG study. 135
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 135
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 130
99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease 128
Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: An electroencephalographic study. 128
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 128
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 128
Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease 128
Enhancement of SPECT Reconstructions by Means of Coregistered MR Data 127
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 127
Neuroimaging findings in mild cognitive impairment 127
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 126
Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms 126
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 125
Cortical sources of awake scalp EEG in eating disorders 125
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 125
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 125
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 124
Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders. 123
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment 123
Regional Cerebral Blood Flow and Anxiety: a correlation study in neurologically normal patients. 122
Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer’s disease. A multicentric EEG study. 122
Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report 122
Phosphatidylserine: Quantitative eeg effects in healthy volunteers 122
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC 122
Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer’s disease. 121
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 121
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 121
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus 121
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 120
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 120
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 120
TIMING OF DISEASE PROGRESSION BY QUANTITATIVE EEG IN ALZHEIMER’S PATIENTS 119
ASSESSMENT OF DEMENTIA IN ETHNIC MINORITY PATIENTS IN EUROPE: A EUROPEAN ALZHEIMER'S DISEASE CONSORTIUM SURVEY. 119
The Von Restorff effect in ageing and Alzheimer's disease. 119
Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study 119
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study 119
Regional Cerebral Blood Flow in Essential Hypertension: data evaluation by a mapping system. 118
Regional cerebral blood flow and prognostic evaluation in Alzheimer's disease 118
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 118
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia 118
Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease 117
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 117
What predicts cognitive decline in de novo Parkinson's disease? 117
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 117
Individual analysis of EEG frequency and band power in mild Alzheimer’s disease. 116
Directionality of EEG synchronization in Alzheimer’s disease subjects. 116
HEMORHEOLOGICAL AND CEREBRAL BLOOD FLOW CHANGES INDUCED BY LDL- APHERESIS IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS. 116
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 116
Primary dysautonomia: Cerebral Blood Flow and hemodynamic findings. Case report. 114
Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes 114
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 114
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia 114
A new frontier for amyloid PET imaging: multiple sclerosis 114
CORTICAL SOURCES OF RESTING EEG RHYTHMS IN MILD COGNITIVE IMPAIRMENT AND SUBJECTIVE MEMORY COMPLAINT. 113
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 113
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 113
A repository based on a dynamically extensible data model supporting multidisciplinary research in neuroscience 113
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 113
Functional compensation in incipient Alzheimer's disease 113
Duplex scanning of neck vessels: need for extending the consensus on indications. 112
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 112
Brain morphometry reproducibility in multi-center 3T MRI studies: A comparison of cross-sectional and longitudinal segmentations. 112
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 112
123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study 112
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 112
Effectiveness of Florbetapir PET Imaging in Changing Patient Management 112
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 112
SPINAL CORD STIMULATION AND CEREBRAL HAEMODYNAMICS. 111
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 111
Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline 111
Parkinson’s Disease Sleep Scale 2: application in an Italian population 111
Cerebral Haemodynamic changes induced by spinal cord stimulation in man 111
Right hemispheric dysfunction in a case of pure progressive aphemia: fusion of multimodal neuroimaging 110
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 110
Evidence of cerebral hypoperfusion in scleroderma patients. 110
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 110
Correlates of contralateral hypoperfusion in chronic stroke patients. 110
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 109
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 109
Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study 109
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 109
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 109
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 109
CEREBRAL BLOOD FLOW RESERVE IN PATIENTS WITH SYNDROME X. 108
Totale 12.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.612
article - articoli 117.659
book - libri 0
conference - conferenze 11.878
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.075
Totale 263.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.913 0 0 0 730 983 1.252 1.641 896 1.077 1.864 1.161 309
2020/20213.736 226 299 293 413 234 423 235 329 278 407 294 305
2021/20225.597 147 340 477 593 199 443 279 1.272 335 509 285 718
2022/20235.422 500 328 75 548 859 988 17 437 1.002 95 498 75
2023/20242.883 181 371 60 361 263 441 184 181 157 72 160 452
2024/20251.387 259 673 258 197 0 0 0 0 0 0 0 0
Totale 40.526